Request for Covid-19 Impact Assessment of this Report
Sales, means the sales volume of Methylphenidate
Revenue, means the sales value of Methylphenidate
This report studies sales (consumption) of Methylphenidate in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Pfizer
Teva
Novartis
Sandoz
GSK
Market Segment by States, covering
California
Texas
New York
Florida
Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Split by applications, this report focuses on sales, market share and growth rate of Methylphenidate in each application, can be divided into
Application 1
Application 2
United States Methylphenidate Market Report 2017
1 Methylphenidate Overview
1.1 Product Overview and Scope of Methylphenidate
1.2 Classification of Methylphenidate
1.2.1 Type I
1.2.2 Type II
1.3 Application of Methylphenidate
1.3.1 Application 1
1.3.2 Application 2
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Methylphenidate (2012-2022)
1.4.1 United States Methylphenidate Sales and Growth Rate (2012-2022)
1.4.2 United States Methylphenidate Revenue and Growth Rate (2012-2022)
2 United States Methylphenidate Competition by Manufacturers
2.1 United States Methylphenidate Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Methylphenidate Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Methylphenidate Average Price by Manufactures (2015 and 2016)
2.4 Methylphenidate Market Competitive Situation and Trends
2.4.1 Methylphenidate Market Concentration Rate
2.4.2 Methylphenidate Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States Methylphenidate Sales (Volume) and Revenue (Value) by States (2012-2017)
3.1 United States Methylphenidate Sales and Market Share by States (2012-2017)
3.2 United States Methylphenidate Revenue and Market Share by States (2012-2017)
3.3 United States Methylphenidate Price by States (2012-2017)
4 United States Methylphenidate Sales (Volume) and Revenue (Value) by Type (2012-2017)
4.1 United States Methylphenidate Sales and Market Share by Type (2012-2017)
4.2 United States Methylphenidate Revenue and Market Share by Type (2012-2017)
4.3 United States Methylphenidate Price by Type (2012-2017)
4.4 United States Methylphenidate Sales Growth Rate by Type (2012-2017)
5 United States Methylphenidate Sales (Volume) by Application (2012-2017)
5.1 United States Methylphenidate Sales and Market Share by Application (2012-2017)
5.2 United States Methylphenidate Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities
6 United States Methylphenidate Manufacturers Profiles/Analysis
6.1 Pfizer
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Methylphenidate Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Pfizer Methylphenidate Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Teva
6.2.2 Methylphenidate Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Teva Methylphenidate Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Novartis
6.3.2 Methylphenidate Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Novartis Methylphenidate Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Sandoz
6.4.2 Methylphenidate Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Sandoz Methylphenidate Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 GSK
6.5.2 Methylphenidate Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 GSK Methylphenidate Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
7 Methylphenidate Manufacturing Cost Analysis
7.1 Methylphenidate Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Methylphenidate
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Methylphenidate Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Methylphenidate Major Manufacturers in 2015
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Methylphenidate Market Forecast (2017-2022)
11.1 United States Methylphenidate Sales, Revenue Forecast (2017-2022)
11.2 United States Methylphenidate Sales Forecast by Type (2017-2022)
11.3 United States Methylphenidate Sales Forecast by Application (2017-2022)
11.4 Methylphenidate Price Forecast (2017-2022)
12 Research Findings and Conclusion
13 Appendix
Methodology
Analyst Introduction
Data Source
Figure Picture of Methylphenidate
Table Classification of Methylphenidate
Figure United States Sales Market Share of Methylphenidate by Type in 2015
Table Application of Methylphenidate
Figure United States Sales Market Share of Methylphenidate by Application in 2015
Figure United States Methylphenidate Sales and Growth Rate (2012-2022)
Figure United States Methylphenidate Revenue and Growth Rate (2012-2022)
Table United States Methylphenidate Sales of Key Manufacturers (2015 and 2016)
Table United States Methylphenidate Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Methylphenidate Sales Share by Manufacturers
Figure 2016 Methylphenidate Sales Share by Manufacturers
Table United States Methylphenidate Revenue by Manufacturers (2015 and 2016)
Table United States Methylphenidate Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Methylphenidate Revenue Share by Manufacturers
Table 2016 United States Methylphenidate Revenue Share by Manufacturers
Table United States Market Methylphenidate Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Methylphenidate Average Price of Key Manufacturers in 2015
Figure Methylphenidate Market Share of Top 3 Manufacturers
Figure Methylphenidate Market Share of Top 5 Manufacturers
Table United States Methylphenidate Sales by States (2012-2017)
Table United States Methylphenidate Sales Share by States (2012-2017)
Figure United States Methylphenidate Sales Market Share by States in 2015
Table United States Methylphenidate Revenue and Market Share by States (2012-2017)
Table United States Methylphenidate Revenue Share by States (2012-2017)
Figure Revenue Market Share of Methylphenidate by States (2012-2017)
Table United States Methylphenidate Price by States (2012-2017)
Table United States Methylphenidate Sales by Type (2012-2017)
Table United States Methylphenidate Sales Share by Type (2012-2017)
Figure United States Methylphenidate Sales Market Share by Type in 2015
Table United States Methylphenidate Revenue and Market Share by Type (2012-2017)
Table United States Methylphenidate Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Methylphenidate by Type (2012-2017)
Table United States Methylphenidate Price by Type (2012-2017)
Figure United States Methylphenidate Sales Growth Rate by Type (2012-2017)
Table United States Methylphenidate Sales by Application (2012-2017)
Table United States Methylphenidate Sales Market Share by Application (2012-2017)
Figure United States Methylphenidate Sales Market Share by Application in 2015
Table United States Methylphenidate Sales Growth Rate by Application (2012-2017)
Figure United States Methylphenidate Sales Growth Rate by Application (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Methylphenidate Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Methylphenidate Sales Market Share (2012-2017)
Table Teva Basic Information List
Table Teva Methylphenidate Sales, Revenue, Price and Gross Margin (2012-2017)
Table Teva Methylphenidate Sales Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis Methylphenidate Sales, Revenue, Price and Gross Margin (2012-2017)
Table Novartis Methylphenidate Sales Market Share (2012-2017)
Table Sandoz Basic Information List
Table Sandoz Methylphenidate Sales, Revenue, Price and Gross Margin (2012-2017)
Table Sandoz Methylphenidate Sales Market Share (2012-2017)
Table GSK Basic Information List
Table GSK Methylphenidate Sales, Revenue, Price and Gross Margin (2012-2017)
Table GSK Methylphenidate Sales Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Methylphenidate
Figure Manufacturing Process Analysis of Methylphenidate
Figure Methylphenidate Industrial Chain Analysis
Table Raw Materials Sources of Methylphenidate Major Manufacturers in 2015
Table Major Buyers of Methylphenidate
Table Distributors/Traders List
Figure United States Methylphenidate Production and Growth Rate Forecast (2017-2022)
Figure United States Methylphenidate Revenue and Growth Rate Forecast (2017-2022)
Table United States Methylphenidate Production Forecast by Type (2017-2022)
Table United States Methylphenidate Consumption Forecast by Application (2017-2022)
Table United States Methylphenidate Sales Forecast by States (2017-2022)
Table United States Methylphenidate Sales Share Forecast by States (2017-2022)
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...